Mapping bloating: what symptom location may reveal about IBS and functional dyspepsia

Lukas Michaja Balsiger, KU Leuven, discusses findings linking upper abdominal bloating more closely to functional dyspepsia and lower abdominal bloating to irritable bowel syndrome (IBS). 

Colon-targeted vitamin B2: how delivery technology could reshape the biotics market

Humiome® B2 uses a patented coating technology intended to transport riboflavin through the upper gastrointestinal tract and release most of it in the ileal-colonic region.

Tumor microbiotas may be less common than previously thought

Tumor microbiotas appear mainly in cancers of the mouth and digestive tract. 

Gut microbes may predict diabetes risk years before diagnosis

Diabetes prevention needs to account for diet-microbiota interactions, because some gut microbes appear to predict diabetes risk differently depending on fiber intake.

Auto-brewery syndrome: when the gut microbiota produces alcohol without drinking

William Fusco, Policlinico Gemelli, discusses the gut fermentation syndrome, a rare condition arising when ethanol-producing bacteria or fungi in the gut generate excessive amounts of alcohol from dietary carbohydrates.

Precancerous growths may trigger long-lasting changes on the gut microbiota

Monitoring or reshaping the gut microbiota after adenoma removal could become part of future strategies to reduce colorectal cancer risk.

Head impacts in football may be linked to gut microbiota changes

Repeated head impacts, even if minor, can have biological effects.

When food triggers pain: the role of mast cells in IBS

Guy Boeckxstaens of KU Leuven explains how mast cells may alter pain signalling through IgE dependent responses to food antigens and activation of the MRGPRX2 receptor. 

Medical visits may rapidly reshape the microbiota of remote communities

The results may inform programs to preserve microbial diversity while delivering essential care.

Gut bacteria metabolite may help breast cancer to grow

Targeting deoxycholic acid (DCA)-producing gut bacteria could be a way to slow breast cancer progression.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.